Mereo BioPharma Group plc - American Depositary Shares —— 季度现金流量表 (NASDAQ:MREO) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 76.39 M68.32 M62.63 M53.6 M45.92 M 负债总额 15.42 M8.24 M8.45 M7 M5 M 权益总额 60.97 M60.08 M54.18 M46.6 M40.92 M 负债及股东权益总额 76.39 M68.32 M62.63 M53.6 M45.92 M 总债务 5.54 M747 K601 K397 K202 K 净债务 -64.27 M-61.74 M-55.52 M-48.3 M-40.79 M

新闻

Mereo BioPharma Group plc (MREO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cantor Fitzgerald maintains Overweight rating on Mereo BioPharma stock

Needham lowers Mereo BioPharma stock price target to $3 on trial data

Five Below To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - American Eagle Outfitters (NYSE:AEO), Apellis Pharmaceuticals (NASDAQ:APLS)

Mereo BioPharma更新setrusumab项目，延长现金储备期限

Mereo BioPharma updates setrusumab program, extends cash runway

美银证券下调Ultragenyx制药股票目标价，因临床试验失败

BofA Securities lowers Ultragenyx Pharma stock price target on failed trials

Leerink重申Ultragenyx Pharma股票评级为"优于大市"

Ultragenyx Pharma stock rating reiterated at Outperform by Leerink

两项三期临床折戟致股价腰斩，杰富瑞看好Ultragenyx (RARE.US)2026年借候选药物反弹，给予“买入”评级

Ultragenyx高管Huizenga出售价值2922美元股票